Research ArticleCancer

Repression of BET activity sensitizes homologous recombination–proficient cancers to PARP inhibition

See allHide authors and affiliations

Science Translational Medicine  26 Jul 2017:
Vol. 9, Issue 400, eaal1645
DOI: 10.1126/scitranslmed.aal1645

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article